酪氨酸激酶抑制剂
药理学
酪氨酸激酶
医学
化学
内科学
生物化学
信号转导
癌症
作者
James Yu,Robin Park,Alireza Tojjari,Arezoo Sadeghipour,Ali Saeed,Anwaar Saeed
标识
DOI:10.1080/13543784.2024.2388571
摘要
Introduction Zanzalintinib (XL092) is a next-generation anti-VEGFR-related multi-targeted TKI that exhibits immunomodulatory effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI